NEWS RELEASE
November 14, 2023, 4PM ET/ 22:00 CET

MDxHealth to Participate in the 35^th Annual Piper Sandler
Healthcare Conference

IRVINE, CA, and HERSTAL, BELGIUM – November 14, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity, Chief Executive Officer, will participate in a fireside chat at the 35^th Piper Sandler Healthcare Conference on Wednesday, November 29, 2023, at 9:00am ET.   A live webcast of the fireside chat will be available on the Company’s website.

35^th Annual Piper Sandler Healthcare Conference
Date: Wednesday, November 29, 2023
Time: 9:00am ET
Webcast: https://event.webcasts.com/starthere.jsp?ei=1644261&tp_key=fb5d2675c4

The 35^th Annual Piper Sandler Healthcare Conference is taking place November 28 - 30, 2023, at the Lotte New York Palace in New York, NY.

About mdxhealth®

mdxhealth is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests are based on proprietary genomic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis and prognosis of urologic cancers and other urologic diseases. The Company’s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Plano, Texas. European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.

For more information:

NOTE: The mdxhealth logo, mdxhealth, Confirm mdx, Select mdx, Resolve mdx, Genomic Prostate Score, GPS and Monitor mdx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.

Attachment

• MDxHealth @ Piper Sandler Healthcare Conference